Medication Administration During Hemodialysis
Most medications during hemodialysis should be administered through the venous (return) line/chamber of the dialysis circuit, NOT through separate peripheral IV lines with normal saline or dextrose.
Administration Through the Venous Line (Return Line)
The following medications are routinely given through the venous line/chamber during dialysis:
Erythropoietin (EPO): Inject into either the arterial or venous blood line ports at any time during hemodialysis. Avoid injection into the venous drip chamber of Fresenius systems as this can result in "trapping" and incomplete mixing with patient's blood 1.
Intravenous Iron (Iron Dextran, Iron Sucrose, Ferric Gluconate): Administer as IV push over 2 minutes through the dialysis line for doses ≤100 mg. For larger doses (500-1,000 mg), dilute in 250 mL normal saline and infuse over 1 hour 1.
Vancomycin: Can be administered during hemodialysis through the dialysis circuit due to favorable pharmacokinetics 2.
Calcitriol: Administer intravenously during dialysis for high-turnover bone disease 2.
Critical Principle: Avoid Separate Peripheral Lines
Using separate peripheral IV lines with normal saline or dextrose for medication administration during dialysis is problematic because:
Increased sodium load: Normal saline (0.9% NaCl) used to dilute drugs and keep catheters open is a major, preventable source of ICU-acquired hypernatremia 3. This is particularly relevant for dialysis patients who already struggle with fluid and sodium balance.
Drug clearance interference: When medications are infused through a central line in the same vessel as the dialysis catheter, drug removal is significantly increased during dialysis. Studies show gentamicin plasma concentrations were reduced by 27% and noradrenaline requirements more than doubled when infusion occurred near the dialysis catheter 4.
Specific Medication Timing Considerations
Medications Given AFTER Dialysis
For patients with renal insufficiency receiving hemodialysis, administer these medications immediately after hemodialysis 5:
- Tuberculosis medications: Isoniazid, rifampin, pyrazinamide, ethambutol, cycloserine, streptomycin, capreomycin
- Rationale: Facilitates directly observed therapy (3x/week) and avoids premature drug removal during dialysis
Medications Requiring Dose Adjustment
When administering through dialysis lines, monitor for:
- Cycloserine, ethambutol, aminoglycosides: Require therapeutic drug monitoring to minimize toxicity while providing effective doses 5
Common Pitfalls to Avoid
Do NOT use the venous drip chamber of certain dialysis systems (Fresenius) for medication injection—use the blood line ports instead 1.
Do NOT routinely establish separate peripheral IV access for medication administration during dialysis—this increases sodium load and complicates fluid management 3.
Do NOT assume all medications can be given at any time—some require post-dialysis timing to avoid removal 5.
Follow each medication with a saline flush when using intraosseous or central access to promote entry into central circulation 6.
Algorithm for Medication Route Selection
During active hemodialysis:
- First choice: Venous line port of dialysis circuit
- Avoid: Separate peripheral IV lines with NS or D5W
- Exception: Medications that should be given after dialysis (see above)
For medications requiring dilution:
- Use normal saline sparingly (minimum volume needed)
- Consider dextrose 5% as diluent to reduce sodium load 3
- Administer through venous line port, not drip chamber
This approach minimizes sodium overload, prevents inadvertent drug removal during dialysis, and simplifies vascular access management 4, 3, 2.